China Overlooks Pneumonia Threat; Pfizer Sees Greater Opportunity For Prevenar In India
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Pneumonia is one of China's great killers but it only gets peripheral attention from health authorities, which presents a challenge for companies like Pfizer that are trying to draw interest for vaccines in emerging markets